Biopsy Devices Market Size By Product (Needle Based Biopsy Gun [Vacuum-Assisted, Fine Needle, Core Needle], Biopsy Guidance System [Manual, Robotic], Biopsy Needles [Disposable, Reusable], Biopsy Forceps [General Biopsy, Hot Biopsy]), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, China, India, Japan, Mexico, Brazil, Argentina, Saudi Arabia, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024
Published Date: August 2016 | 81 Pages | Report ID: GMI731 Report Format: PDF
Biopsy Devices Market size was USD 1.75 billion in 2015, and is expected to grow at 6.5% CAGR from 2016 to 2024.
U.S. Biopsy Devices Market Size, by Product, 2012- 2024 (USD Million)
Increasing prevalence of cancer, growing demand for minimally invasive medical procedures, and increased spending for effective diagnostic procedures are some of the pivotal factors driving the global biopsy devices market.
Statistics published by the International Agency for Research on Cancer shows that, the global incidence of cancer in 2012 was 14.1 million (excluding non-melanoma skin cancer), and expected to reach 23.6 million by 2030. The growing number of cancer patients is set to generate demand for biopsy procedures. Moreover, future projections also suggest an increase in prevalence, ensuring the lucrative industry growth in the coming years.
The introduction of government reforms aimed at improving reimbursement cover in the countries, such as the Obamacare Act is expected to widen the consumer base in U.S. High penetration rates of technologically advanced equipment such as the vacuum assisted systems and disposable products is also expected to stimulate biopsy devices market growth.
Aging being the greatest risk for developing cancer, rise in geriatric population should certainly lead to an increasing cancer prevalence. Increasing old age population with huge untapped opportunities in countries such as India, Japan and China is expected to drive market growth during the forecast timeline.
Biopsy Devices Market, By Product
Global biopsy devices market share was dominated by guidance systems, followed by needle-based biopsy guns, and biopsy needles respectively. Guidance systems contributed 43% to the overall revenue in 2015, with target market size slated to exceed USD 1.1 billion by 2024. The high prices associated with robotic guidance systems contributed considerably to segment revenue.
The vacuum-assisted biopsy devices market size contributed major revenue share to the needle-based guns. The demand for this product is on the rise due to growing preference for minimally invasive procedures. Guidance systems demand was predominantly driven by manual type in 2015. Hot or insulated forceps are insulated with fluorinated ethylene polymer. These are used for removing polyps of the mucosal membranes and for the treatment of vascular ectasias of the GI tract. It utilizes high frequency current to coagulate the mucosal membrane. Curettes are categorized into two types namely reusable and disposable. Disposable curettes are expected to register higher growth, owing to their ability to avoid cross contamination and infection.
Biopsy Devices Market, By Region
North America was the largest regional industry, contributing to global share by over 55% in 2015, followed by Europe and Asia Pacific. U.S. biopsy devices market size was valued at close to USD 1 billion in 2015, which was over 80% of the North American industry. This can be attributed to the increasing awareness regarding cancer diagnosis, and continued funding activities for effective diagnostics procedures.
Europe biopsy devices market share is set to see moderate growth, with Germany being responsible for over 28% sales in 2015.
Asia Pacific, dominated by China and India biopsy devices market registers the highest growth rate of 11.8% from 2016 to 2024 and is eyed upon as the most lucrative market for investment. Presence of huge number of patients with unmet needs coupled with rapidly improving healthcare infrastructure will drive regional growth.
Competitive Market Share
Global biopsy device market share is oligopolistic in nature with very few players accounting to over 90% of the market share in 2015. The industry players have witnessed consolidation in order to widen product portfolio and expand distribution networks. C.R. Bard dominated the global share in 2015. Adoption of sustainable strategies such as mergers and acquisitions and new product development contributed towards its majority market share holding.
The other key players include Devicor Medical Products Inc., CareFusion Corporation and Hologic Inc. The growing popularity of minimally invasive medical procedures due to fewer trauma and quick recovery than invasive procedures, along with less duration of hospital stays will fuel future market demand. Needle-based biopsies are preferred due to very little invasive pain before undergoing a complex surgical intervention. It also enable accurate cancer detection and allow physician determine the best suitable treatment for the patient.
Biopsy Devices Industry Background
The industry is highly influenced by growing prevalence of cancer, rising patient awareness regarding its diagnosis, and better treatment options. It is also receiving healthy funding and grants for R&D of innovative diagnostic treatments. However, innovation and product development are associated with high cost of R&D, leading to higher selling prices. High product prices have reduced the affordability of this equipment, especially vacuum-assisted and robotic guidance systems. Independent medical practitioners are reluctant to invest in capital intensive equipment and instead opt to conduct procedures using already established systems in hospitals and larger clinics.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security